Facilitating Innovative Nuclear Diagnostics (FIND) Act
Nuclear medicine scans are often the most effective AND cost-effective way to diagnose certain diseases, providing the best possible care for patients, but...
Patients lack access to nuclear medicine scans that could change the course of their treatment.
Physicians are less likely to administer a game-changing PET or other nuclear medicine scan because of lack of appropriate reimbursement.
Hospitals are facing the decision of discontinuing certain nuclear medicine procedures, because Medicare does not cover anywhere near full drug cost.
Companies that have innovated life-changing nuclear medicine drugs are having trouble keeping them in production and developing new ones.
Medicare is paying for unnecessary therapies, surgery, and hospital stays because it continues to treat these drugs as supplies and bundles them in with the scan.
The bi-partisan Facilitating Innovative Nuclear Diagnostics (FIND) Act will ensure patient access to these imaging procedures.